|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 6.640 USD | -2.06% |
|
+15.08% | +59.62% |
| 09-20 | Precision BioSciences, Inc.(NasdaqCM:DTIL) added to S&P Global BMI Index | CI |
| 08-24 | Precision BioSciences, Inc. Commences Dosing In Phase 1/2 Function-Dmd Study | CI |
| Market Cap | 183M 164M 151M 137M 257M 17.4B 261M 1.82B 720M 9.11B 688M 673M 28.74B | P/E 2026 * |
-1.84x | P/E 2027 * | -2.45x |
|---|---|---|---|---|---|
| Enterprise Value | 183M 164M 151M 137M 257M 17.4B 261M 1.82B 720M 9.11B 688M 673M 28.74B | EV / Sales 2026 * |
13.6x | EV / Sales 2027 * | 20.7x |
| Free-Float |
91.87% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DTIL | Delayed | |
CBOE
| DTIL | Real-time | |
Deutsche Boerse AG
| PBS0 | Delayed | |
Tradegate
| PBS0 | Real-time | |
Boerse Muenchen
| PBS0 | Real-time | |
Börse Stuttgart
| PBS0 | Delayed |
Last Transcript: Precision BioSciences, Inc.
| 1 day | -2.06% | ||
| 1 week | +15.08% | ||
| Current month | +6.07% | ||
| 1 month | +4.40% | ||
| 3 months | -9.41% | ||
| 6 months | -9.17% | ||
| Current year | +59.62% |
| 1 week | 5.77 | 6.92 | |
| 1 month | 5.72 | 6.92 | |
| Current year | 3.53 | 9.62 | |
| 1 year | 3.53 | 9.62 | |
| 3 years | 3.53 | 19.43 | |
| 5 years | 3.53 | 326.4 | |
| 10 years | 3.53 | 710.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Amoroso
CEO | Chief Executive Officer | 48 | 2021-10-14 |
Jeff Smith
CTO | Chief Tech/Sci/R&D Officer | 53 | 2006-01-25 |
Naresh Tanna
DFI | Director of Finance/CFO | 45 | 2026-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Buehler
CHM | Chairman | 68 | 2020-10-31 |
Geno Germano
BRD | Director/Board Member | 65 | 2020-03-09 |
Stanley Frankel
BRD | Director/Board Member | 67 | 2021-04-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/28/26 | Buy | Director | 1,000 | 0.0042% | ||
| 9/25/26 | Buy | Director | 2,609 | 0.0108% | ||
| 9/25/26 | Buy | Director | 1,135 | 0.0047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.06% | +15.08% | -4.18% | -25.53% | 183M | ||
| +2.41% | +0.29% | +42.02% | +71.57% | 64.69B | ||
| -0.15% | +7.50% | +11.01% | +73.48% | 54.78B | ||
| +0.57% | +4.60% | +10.07% | +92.86% | 53.49B | ||
| +0.37% | +4.67% | +27.03% | +52.07% | 45.98B | ||
| -1.21% | +2.32% | +21.80% | +123.81% | 42.94B | ||
| -0.37% | +5.07% | +249.91% | +918.74% | 40.08B | ||
| +0.05% | +0.21% | +18.26% | +58.53% | 33.52B | ||
| -0.38% | +5.68% | +36.43% | +27.54% | 23.67B | ||
| +1.19% | -4.98% | +29.01% | -0.65% | 23.97B | ||
| Average | +0.04% | +3.68% | +44.14% | +139.24% | 38.33B | |
| Weighted average by Cap. | +0.39% | +2.74% | +47.55% | +158.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.48M 12.04M 11.11M 10.08M 18.88M 1.28B 19.17M 134M 52.94M 670M 50.6M 49.52M 2.11B | 8.88M 7.92M 7.31M 6.64M 12.43M 843M 12.62M 88.07M 34.84M 441M 33.3M 32.59M 1.39B |
| Net income | -94.18M -84.08M -77.61M -70.43M -132M -8.94B -134M -935M -370M -4.68B -353M -346M -14.77B | -96.95M -86.55M -79.89M -72.5M -136M -9.2B -138M -962M -381M -4.82B -364M -356M -15.2B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | US$6.640 | -2.06% | 275,533 |
| 26-10-22 | US$6.780 | +1.04% | 132,428 |
| 26-10-21 | US$6.710 | +2.29% | 231,040 |
| 26-10-20 | US$6.560 | +5.98% | 213,655 |
| 26-10-19 | US$6.190 | +7.28% | 176,469 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DTIL Stock
Select your edition
All financial news and data tailored to specific country editions

















